HOC is our outreach and engagement site which connects us with healthcare professionals, industry personnel and academics worldwide.
Our HOC platform shares blogs from experienced medical writers around the world, bringing you tips on good communication, evaluations of current health economics and outcomes research and healthcare evidence. Mixed in with great information you will find a light-hearted approach to current issues, some valuable downloads, as well as references for further reading.
By Mary Gabb (mary.gabb@rxcomms.com) A frequently overlooked professional skill – especially among scientists – is public speaking, yet the inability to effectively communicate your work can place significant roadblocks in…
Details
By David Woods (david.woods@rxcomms.com) A pair of economists, Charles Jones of the University of California at Berkeley and Robert Hall of Stanford University, predict that the share of income devoted…
Details
By David Woods (david.woods@rxcomms.com) Call them Sermoans, Sermophiles, or just plain members, the 32,000 physicians enrolled in Sermo could be changing the way that pharmaceutical companies interact with healthcare professionals.…
Details
By Robert Hand (robert.hand@rxcomms.com) As a health economist and outcomes researcher, you may work primarily within a single country. Naturally, you know the economic, regulatory, and management issues of that…
Details
By Kevin Frick (kevin.frick@rxcomms.com) It is ironic that we should have to answer the question: “what is the value of outcomes research?” when outcomes research is a key component of…
Details
By Robert Hand (robert.hand@rxcomms.com) Under the title Legacy of Leadership, the American Medical Writers Association (AMWA) held its 67th Annual Conference on October 11–13 in Atlanta, Georgia. About 1000 medical…
Details
By David Woods (david.woods@rxcomms.com) On January 1st 2006, Dr Dennis Gross retired from Merck after 28 years; the following day, he took up his present position as Associate Dean, Masters…
Details
Our HOC People person this month, Dennis M. Gross, PhD, is an associate dean at Thomas Jefferson University where he also teaches courses in pharmacology and toxicology. He emailed us these thoughts on non-adherence.
Details
By Mary Gabb (mary.gabb@rxcomms.com) As we reported in last month’s HOC, the past few years have witnessed a surge of interest in the role of adherence in health economics research,…
Details
By David Woods (david.woods@rxcomms.com) Writing in Pharmatech a couple of years ago, Dr Faiz Kermani observed that “many clinical trials are plagued by delays and setbacks that can cost pharmaceutical…
Details
